0001214659-18-003060.txt : 20180426 0001214659-18-003060.hdr.sgml : 20180426 20180426180750 ACCESSION NUMBER: 0001214659-18-003060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180425 FILED AS OF DATE: 20180426 DATE AS OF CHANGE: 20180426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHEN ISAN CENTRAL INDEX KEY: 0001586218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 18780077 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS, INC. STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-41802.xml PRIMARY DOCUMENT X0306 4 2018-04-25 0001576263 Mirati Therapeutics, Inc. MRTX 0001586218 CHEN ISAN C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 false true false false EVP, Chief Medical Officer Common Stock 2018-04-25 4 M false 2 5.40 A 18800 D Common Stock 2018-04-25 4 M false 10124 15.79 A 28924 D Common Stock 2018-04-25 4 M false 412 17.41 A 29336 D Common Stock 2018-04-25 4 M false 2500 21.51 A 31836 D Common Stock 110 I By Chen Living Trust Employee Stock Option (Right to Buy) 5.40 2018-04-25 4 M false 2 0 D 2027-01-25 Common Stock 2 49998 D Employee Stock Option (Right to Buy) 15.79 2018-04-25 4 M false 10124 0 D 2023-11-07 Common Stock 10124 96668 D Employee Stock Option (Right to Buy) 17.41 2018-04-25 4 M false 412 0 D 2024-05-20 Common Stock 412 6188 D Employee Stock Option (Right to Buy) 21.51 2018-04-25 4 M false 2500 0 D 2025-02-03 Common Stock 2500 27500 D 1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested. /s/ Vickie Reed, Attorney-in-Fact 2018-04-26